Mary C. Scherer, Chief Accounting Officer at Cardinal Health Inc. (NYSE:CAH), recently sold 3,504 common shares of the company. The shares were sold at a weighted average price of $123.55, resulting in a total transaction value of $432,919. Following this sale, Scherer retains ownership of 8,752 shares in the company. These transactions were executed on November 14, as disclosed in a recent SEC filing.
In other recent news, Cardinal Health Inc. reported a robust start to fiscal year 2025, despite a 4% decrease in total revenue. The company's operational performance, particularly in the Pharmaceutical (TADAWUL:2070) and Specialty Solutions segment, led to an increased earnings per share (EPS) guidance to $7.75-$7.90 and an improved cash flow forecast. The company also announced plans to acquire Integrated Oncology Network for $1.1 billion.
In further developments, Cardinal Health shareholders recently elected the company's board of directors and approved executive compensation. All 10 nominees were elected to the board, demonstrating shareholder confidence in the company's governance. However, a proposal prohibiting the re-nomination of any director failing to receive a majority vote was not approved.
The company's full-year COVID-19 vaccine revenue growth is expected to remain at 18%-20%, while Theranostics products in oncology and at-home solutions saw over 20% revenue growth. Despite challenges faced in the GMPD segment due to recent hurricanes, Cardinal Health remains optimistic about its long-term profit goals and growth strategies.
InvestingPro Insights
Cardinal Health Inc. (NYSE:CAH) has been demonstrating strong financial performance, as evidenced by recent InvestingPro data. The company's market capitalization stands at $29.46 billion, reflecting its significant presence in the Healthcare Providers & Services industry. Cardinal Health's revenue for the last twelve months reached an impressive $224.45 billion, with a 6.87% growth rate, indicating robust business operations.
InvestingPro Tips highlight that Cardinal Health has raised its dividend for 36 consecutive years, showcasing a commitment to shareholder returns. This aligns with the company's strong financial position, as cash flows can sufficiently cover interest payments. The stock's recent performance has been noteworthy, with a 29.9% price total return over the past six months and an 18.38% return in the last three months.
It's worth noting that Cardinal Health is trading near its 52-week high, with the current price at 96.16% of that peak. This strength is further supported by analysts' expectations of profitability for the current year and the company's positive net income growth projections.
For investors seeking more comprehensive insights, InvestingPro offers 17 additional tips for Cardinal Health, providing a deeper understanding of the company's financial health and market position.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.